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Abstract
Background: Evaluation of physiology during capture and anesthesia of free-ranging wildlife is useful for determining
the effect that capture methods have on both ecological research results and animal welfare. This study evaluates
capture and anesthesia of moose (Alces alces) with etorphine-xylazine-acepromazine in Northern Sweden.
Methods: Fifteen adult moose aged 3–15 years were darted from a helicopter with a combination of 3.37 mg etorphine,
75 mg xylazine, and 15 mg acepromazine. Paired arterial blood samples were collected 15 minutes apart with the first
sample at 15–23 minutes after darting and were analyzed immediately with an i-STAT
W1 Portable Clinical Analyzer.
Results: All animals developed hypoxemia (PaO2 <10 kPa) with nine animals having marked hypoxemia (PaO2 5.5-8 kPa).
All moose were acidemic (ph<7.35) with nine moose having marked acidemia (pH<7.20). For PaCO2, 14 moose had mild
hypercapnia (PaCO2 6-8 kPa) and two had marked hypercapnia (PaCO2>8 kPa). Pulse, respiratory rate, pH and HCO3
increased significantly over time from darting whereas lactate decreased.
Conclusions: The hypoxemia found in this study is a strong indication for investigating alternative drug doses or
combinations or treatment with supplemental oxygen.
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Background
Potent opioids (etorphine, carfentanil or thiafentanil) are
considered the drugs of choice for immobilization of free-
ranging moose [1-3]. In Sweden, 1,263 moose captures
were carried out with etorphine-acepromazine-xylazine
from a helicopter 1984–2003, with an overall mortality
rate of 1.0% [4]. During the same period, 1,491 captures of
moose were done in Norway with etorphine, with an
overall mortality rate of 0.5% [4]. Other opioids and com-
binations of opioids used in moose include carfentanil-
xylazine [5,6], carfentanil [6] and thiafentanil [3]. In other
studies of different subpopulations of moose, xylazine and
carfentanil in combination resulted in much higher
mortality rates [4-6]. A study of moose captures using
thiafentanil [3] reported induction and recovery times of
less than 4 minutes, but the mortality rate was 5% within
the first 30 days of capture with causes of death including
pneumonia, malnutrition and undetermined
W h i l el o wm o r t a l i t yr a t e sa r ei m p o r t a n t ,t h e yc a n n o t
stand alone as the measure of capture success and
immobilization safety. Evaluation of capture physiology has
both research and welfare implications. Altered physiology
during capture can affect research results including move-
ment and activity levels [7]. No effect on calving rates of
captured females was documented when a combination of
carfentanil, fentanyl, xylazine and hyaluronidase was used
[8]. However, calves born to females captured in the last 3
months of pregnancy had lowered postnatal survivorship
than those born to females not captured during this period
[8]. A recent study evaluating movement pre and post
capture with etorphine-acepromazine-xylazine found
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capture with no further residual effect [9].
Arterial blood gases and acid-base status are valuable
for evaluating capture methods and their physiological
effects. Acidosis and hypoxemia could have many undesir-
able and undetected effects including organ dysfunction
[10] and damage to the brain [11], liver [12,13] and kid-
neys [14], and in sheep, has been shown to result in fetal
hypoxemia [15], leading to fetal brain damage [16]. These
effects are difficult to evaluate in wildlife but may have
consequences for the quality of results of the ecological
studies dependent on capturing representative animals.
To our knowledge, physiological evaluation of immo-
bilized moose including blood gases and acid–base sta-
tus has not been reported previously. The aim of this
study was to evaluate the physiology, including vital
signs and blood oxygen and acid–base status, of moose
immobilized with etorphine-acepromazine-xylazine.
Methods
The study was conducted during March 2010 in
Nikkaluokta, Sweden (67°52’ N, 18°66’ E). Twelve female
and three male moose three to fifteen years old were
captured and collared as part of ongoing research. All
captures were approved by the Ethical Committee on
Animal Experiments in Umeå, Sweden. All moose had
been captured and equipped with radiocollars and/or
GPS collars three years previously. The moose were aged
based on tooth wear (calibrated with sectioning [17])
during immobilizations one year prior to these captures.
Animals were not weighed.
The moose were located based on GPS positions and
radio tracking. A CO2 powered rifle (Dan-Inject, Børkop,
Denmark) was used to deliver a dart injection in the glu-
teal or epaxial muscles from less than 10 m away by heli-
copter. The dart contained a mixture of 75 mg xylazine
(Rompun
W, Bayer AG, Leverkusen D-51368, Germany),
3.37 mg etorphine and 15.0 mg acepromazine (Large Ani-
mal Immobilon
W, Novartis Animal Health, Litlington, UK,
2.25 mg/ml etorphine and 10 mg/ml acepromazine).
Moose not recumbent after 15 minutes were given a sec-
ond dart with 2/3rds of the original dose. All darts had a
Recco tracking device (Recco AB, Lidingö, Sweden) to
ensure that they could be recovered.
Altitude was determined by correlating GPS points
recorded from the helicopter with a detailed terrain
map. Snow depth was measured in three places along
the final 15 meters that the moose walked with a meter
stick and the average was used. Ambient temperature
and barometric pressure were also recorded.
Recorded variables included time from sighting animal
to successful darting (darting time), time from darting to
recumbency (induction time), and estimated distance
run (distance from initial sighting to recumbency). All
moose were maintained in sternal recumbency during
immobilization. Pulse rate (by palpation of auricular ar-
tery), respiratory rate (counting thoracic excursions), and
rectal temperature (using a digital thermometer) were mea-
sured as soon as possible after recumbency (upon capture)
and repeated 15 minutes later. On capture and approxi-
mately 15 minutes later, arterial blood samples were
collected anaerobically from the auricular artery using
self-filling arterial syringes with heparin (PICO™ 70,
Radiometer Copenhagen, Brønshøj, Denmark) and ana-
lyzed immediately with an i-STAT
W1 Portable Clinical
Analyzer and i-STAT
W CG4+ and EC8+ cartridges (Abbott
Laboratories, Abbott Park, Illinois 60064–6048, USA). The
i-STAT
W1 analyzer was kept in an insulated box to keep it
at optimum temperature (16-30°C), with warm water
bottles used as needed. Measured variables included pH,
hematocrit, partial pressure of arterial oxygen (PaO2)a n d
carbon dioxide (PaCO2) and whole blood concentrations of
lactate, sodium (Na), potassium (K), chloride (Cl), and glu-
cose. PaO2,P a C O 2 and pH were corrected based on rectal
temperature. Calculated values included concentration of
bicarbonate (HCO3), hemoglobin, oxygen hemoglobin sat-
uration (SaO2%), base excess (BE), and anion gap (AG).
Etorphine was reversed with diprenorphine (Large
Animal Revivon
W 3 mg/ml, Novartis Animal Health) at
a dose ratio at 1.33 mg per mg etorphine. Xylazine was
reversed with a ratio of 0.1 mg atipamezole per mg xyla-
zine (Antisedan
W, 5 mg/ml, Orion Pharma Animal
Health, Turku, Finland) [18]. Time from darting until
time of administration of reversal drugs and time from
reversal until standing were recorded.
Hypoxemia was defined as mild (PaO2 8.0-10.0 kPa),
marked (PaO2 5.5-8.0 kPa), or severe (PaO2 <5.5 kPa).
Acidemia was defined as a pH <7.35, and acidemia was
considered marked if pH <7.20. Hypocapnia was defined
as a PaCO2 <4.5 kPa and hypercapnia was defined as
mild (PaCO2 6–8 kPa) or marked (PaCO2 >8 kPa).
The alveolar oxygen tension (PAO2) was calculated based
on the alveolar gas equation [PAO2=FiO2(PB−PH20)−
(PaCO2/RQ)]. FiO2 = fraction of inspired oxygen (0.21).
PH2O = saturated vapor pressure for water at 37°C (47
mmHg). Barometric pressure (PB) was recorded with the
iSTAT and 1.0 was used for the respiratory quotient (RQ)
[19]. The aveolar-arterial oxygen tension difference [P(A-a)
O2] was calculated by subtracting PaO2 from PAO2.
Statistics
Variables were first tested for normality using
Kolmogorov-Smirnov test for normality (p<0.05). Results
for the first and second sample (both measured and cal-
culated values) were compared using Wilcoxon signed
rank test. Statistics were carried out using JMP
W 9.0.2
(SAS Institute, NC, USA).
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Moose were either in sternal recumbency on initial ap-
proach, or placed in sternal recumbency before sam-
pling. The immobilization in general was characterized
by open eyes, pupils positioned centrally and the head
lowered, often into the snow, in which case the snow
was cleared from the area in front of their nostrils
(Figure 1).
Mean ± SD (range) of ambient temperature was −8±3
(−4t o−15) degrees Celsius and snow depth was 52± 15
(30–75) cm. Altitude ranged from 444 to 595 meters
above sea level with a barometric pressure from 694 to
708 mmHg. The initial doses used in this study were
sufficient to immobilize 12/15 (80%) of moose on the
first dart. Recumbency occurred in 6.5±2.5 (3.5-11.5)
minutes except for three animals that required a second
dart 16–21 minutes after darting. These three animals
were recumbent in 2, 3 and 9 minutes after the second
dart. Between discovery and the first dart, moose moved
an estimated 428 ±303 (20–1,100) meters in 3.5±3
(1–13) minutes. Once recumbent, no animals required
supplemental drug doses. Atipamezole and diprenor-
phine were administered intravenously at 43± 10
(30–66) minutes after last darting. Mean time to stand-
ing was 2:12 ± 0:28 (1:30–3:20) min:sec.
Physiological variables and arterial blood gas results
for moose with paired samples are presented in Table 1.
All variables were normally distributed except for rectal
temperature, and SaO2. All 15 moose had at least one
PaO2 measurement below 10 kPa (mild hypoxemia) and
9 moose were between 5.5-8.0 kPa (marked hypoxemia)
with two moose exhibiting severe hypoxemia (<5.5 kPa).
For PaCO2, 14 moose had at least one measurement
above 6kPa (mild hypercapnia) and two had at least one
measurement above 8 kPa (marked hypercapnia). PaO2
did not significantly change between sample 1 and 2
(Table 1). All moose were acidemic (pH< 7.35) and the
acidemia was classified as marked in 9/15 moose
(pH<7.20). The PAO2 and P(A-a)O2 did not differ be-
tween the first and second samples. PAO2 was 11.3± 1.0
(9.8-13.2) kPa between 15–23 minutes and 11.3 ±1.0
(9.8-13.2) kPa from 29–43 minutes. P(A-a)O2 was 3.0 ±
1.4 (0.7-5.6) kPa between 15–23 minutes and 3.3± 1.2
(1.1-4.9) kPa from 29–43 minutes.
All moose were living seven months after capture ex-
cept for one male, which was harvested during the regu-
lar hunting season six months after capture.
Discussion
This study of 15 animals presents physiological variables
in moose anesthetized with etorphine-acepromazine-
xylazine. To the best of our knowledge, this type of
evaluation has not previously been reported for
anesthetic protocols in moose. This study documented
hypoxemia, hypercapnia and acidemia in moose immo-
bilized with this combination.
Although the mean induction time for the 12 moose
immobilized with one dart in our study was acceptable,
it was over 2 minutes longer than the 4.4 ±2.6 minutes
reported in etorphine-immobilized moose [20]. Pulse
and rectal temperature did not change over time and
were within acceptable ranges for this species. Guide-
lines for cervid anesthesia include taking corrective mea-
sures when a rectal temperature over 40°C or a heart
rate under 30 beats per minute is observed [2].
Although the moose were kept in sternal recumbency
and snow was cleared from around the nose, the pos-
ition with the head lowered, may have added to the
drug-induced hypoxemia seen in this study. In moose
immobilized with etorphine alone, moose were in sternal
recumbency [1,21] with the head raised. Adding xylazine
to opioids is not recommended in moose [1] as it results
in a deeper immobilization, affecting the positioning
(lateral without deep snow, head down) [1,2,22] and
resulting in an increased risk of adverse effects including
Figure 1 Moose with head in the snow. This moose, immobilized
with the combination of etorphine-acepromazine-xylazine, exhibits
open eyes with the pupils positioned centrally and the head
lowered into the snow.
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oximetry (J. M. Arnemo, unpublished data) regurgitation
and risk of pneumonia [1,22] and higher mortality [23].
Opioids, such as etorphine, produce dose-dependent re-
spiratory depression, primarily by causing the respiratory
center of the brain stem to be less responsive to
increased PaCO2 [24]. The responsiveness to PaCO2 is
further decreased by coadministered sedatives or other
anesthetic agents including phenothiazines [24], such as
acepromazine. Xylazine which when used alone, causes a
dose-dependent decreased responsiveness to CO2 that is
further compounded when combined with opioids [25].
In sheep, xylazine was shown to cause pulmonary edema
resulting in hypoxemia and lung tissue damage [26].
Moderate to severe hypoxemia has also been docu-
mented in other ruminants anesthetized with alpha-2
combinations including wood bison (Bison bison) [27],
mule deer (Odocoileus heminus) [28,29], wapiti (Cervus
canadensis) [29,30] and white tailed-deer (Odocoileus
virginianus) [31]. Hypoxemia was also found in cases
where alpha-2 combinations were used in combination
with opioids [28,30]. The hypoxemia seen in this study
as in studies of other ruminants, indicates that oxy-
gen supplementation is indicated in these species. In
a study of nine wapiti immobilized with xylazine-tile-
tamine-zolazepam, all were initially hypoxemic and in
all, the hypoxemia resolved after administration of 10
L/minute of nasal oxygen for only five minutes [29].
A study comparing nasal oxygen and medical air sup-
plementation in wapiti before and during anesthesia
with carfentanil and xylazine found that wapiti receiv-
ing 10 L/minute of oxygen had a significantly faster
induction and recovery, less hypoxemia, less rigidity
and movement, but more apnea, hypercapnia and
acidosis [32]. A review of alpha-2 agonist and hypox-
emia concluded that hypoxemia in large ruminants
such as cattle are primarily due to hypoventiliation
and perfusion mismatching due to recumbency
whereas sheep given xylazine can develop pulmonary
edema [33]. Evaluation of oxygen flow rates necessary
Table 1 Physiological variables during anesthesia of moose
Time from darting T1: 15–23 minutes T2: 29–43 minutes
Variable Units N Mean±SD (Range) Mean±SD (Range) Z
Pulse Rate beats/min 10 46±8 (32–60) 45±8 (36–60) NSD
Repiratory Rate breaths/min 10 39±7 (28–52) 34±9 (22–48) NSD
Rectal Temp
# C 10 37.7±0.5 (37.2-38.7) 37.4±0.6 (36.6-38.7) NSD
PaO2
* kPa 10 8.46±1.90 (5.2-10.8) 8.12±1.94 (4.8-11) NSD
mmHg 10 63.5±14.2 (39.0-81.0) 60.9±14.6 (36.0-82.5) NSD
PaCO2
* kPa 10 6.98±1.12 (5.29-8.63) 7.21±1.14 (5.76-9.31) NSD
mmHg 10 52.4±8.4 (39.7-64.7) 54.1±5.9 (43.2-69.8) NSD
SaO2 % 10 79±13 (70–89) 79±20 (49–95) NSD
pH
*,† 10 7.15±0.12 (6.95-7.35) 7.21±0.10 (7.03-7.35) 0.0002
PAO2 kPa 10 11.3±1.0 (9.8-13.2) 11.3±1.0(9.8-13.2)
mmHg 84.9 ± 7.4 (73.7-99.1) 85.1 ± 7.4 (73.7-99.1) NSD
P(A-a)O2 kPa 10 3.0±1.4 (0.7-5.6) 3.3±1.2 (1.1-4.9)
mmHg 22.2 ± 10.2 (5.3-42.1) 24.8 ±8.8 (8.1-36.8) NSD
Lactate
† mmol/l 10 12.6±5.1 (5.0-19.8) 9.8±4.7 (2.8-16.4) 0.0002
Anion Gap
† mEq/l 9 20.9±3.9 (16–26) 18.6±4.2 (12–25) 0.0059
Na mmol/l 9 137.6±1.0 (136–139) 136.8±1.6 (135–140) NSD
K
† mmol/l 9 3.5±0.3 (2.9-3.8) 3.7±0.3 (3.2-4.1) 0.0391
Cl mmol/l 9 101.9±2.0 (99–105) 101.8±3.1 (98–108) NSD
Glucose mmol/l 9 6.6±0.6 (5.7-7.6) 7.0±1.0 (5.6-8.5) NSD
Hct
† % PCV 9 41.6±4.2 (33–46) 38.6±3.2 (33.0-42.0) 0.0063
Hb
† g/L 9 141±14 (112–143) 131±11 (112–143) 0.0059
BE
† mmol/l 10 −10.8±5.8 (−18-(−1)) −6.4±5.2 (−13-(+3)) 0.0002
HCO3
† mmol/l 10 18.0±4.0 (13.4-24.5) 21.5±4.0 (17.0-28.9) 0.0002
*Blood gas and pH values were corrected to rectal temperature.
Mean and standard deviation of physiological variables at 15–23 and 29–43 minutes for moose darted once. SaO2=hemoglobin oxygen saturation. PaO2 and
PaCO2 = partial pressures of arterial oxygen and carbon dioxide.
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The hypercapnia noted indicates hypoventilation,
which also causes hypoxemia [34]. Hypercapnia has been
documented during anesthesia in a number of ruminants
including wood bison [27], mule deer [28,29] and wapiti
[29,30]. In a study comparing oxygen and medical air
supplementation in wapiti, both groups had increasing
PaCO2 over time, but this was significantly higher in the
group receiving oxygen [32]. Under ordinary conditions,
increased PaCO2 stimulates and increases central re-
spiratory drive and severely decreased PaO2 can also
stimulate increased ventilation [35], however anesthetics
depress the ventilatory response initiated by increased
PaCO2. When increasing FiO2 and therefore PaO2
in carfentanil-xylazine immobilised elk a significantly
increased PaCO2 was observed which is highly indicative
that hypoxemia in the Elk breathing pure air had
resulted in increased ventilatory drive [32]. Hypercapnia
and decreased pH also cause a right shift in the oxygen-
hemoglobin dissociation curve, increasing the unloading
of oxygen at tissues, enhancing oxygen delivery [35].
Both etorphine and xylazine are likely contributing to
the hypoventilation and intrapulmonary causes of hyp-
oxemia and resulting hypoxemia and hypercapnia. As
neither the hypercapnia nor hypoxemia changed with
time, this indicates continued respiratory depression.
PAO2 are mostly governed by uptake of oxygen by
pulmonary capillary blood and replacement by alveolar
ventilation. Normal values for PAO2 for normal animals
at sea level are around 13 kPa [34]. The initial PAO2 in
this study was 11.3 ±1.0 (9.8-13.2) kPa. P(A-a)O2 was
3.0± 1.4 (0.7-5.6) kPa (Normal is generally less than 2
kPa with over 3.3 considered abnormal [35]) indicating
that intrapulmonary problems like V/Q mismatch,
physiological shunting or diffusion impairment could be
contributing factors. Within the study group, we found
large variations between animals ranging from normal
function to animals with a markedly high P(A-a)O2.
The hypoxemia seen in all animals could be due to a
variety of possible causes including low inspired O2
pressure (altitude), hypoventilation, V/Q mismatch, pul-
monary shunting or diffusion limitations. Barometric
pressure ranged from 694 to 708 mmHg, so low baro-
metric [35] pressure would not be expected to contrib-
ute significantly to the hypoxemia observed. The spread
of P(A-a)O2 a would indicate most moose have a pul-
monary problem in addition to likely hypoventilation. A
future evaluation of the effect of positioning (head uphill
vs. downhill vs. flat ground) is warranted, however, these
large animals can be difficult to reposition beyond mov-
ing from lateral to sternal recumbency.
We found a marked acidosis, both respiratory and
metabolic. The metabolic part of the acidosis improved
with time, reflected in a significantly increased pH and
decreased lactate and increased BE in the second sam-
ple. The severe lactic-acidemia decreased significantly
over time, indicating either decreasing lactate produc-
tion, increased lactate metabolism or a combination of
these. The mean lactate levels in arterial blood in the
present study were slightly higher than the mean venous
lactate levels in etorphine-immobilized moose reported
by [20] who found significantly lower lactic acid levels in
animals with longer induction times and with increased
time between darting and sampling. That study found a
plasma lactate of 9.3±2.1 (2.9-12.5) mmol/L and blood
was sampled at 11.0 ±4.1 (6.0-19.9) minutes after dart-
ing. The moose in the current study had both longer in-
duction times, a later sampling time and higher lactate
than found in etorphine-immobilized moose [20]. Fur-
thermore, lactate is normally higher in venous samples than
in arterial [36]. This indicates that moose immobilized with
etorphine-xylazine-acepromazine had higher lactate levels
than moose immobilized with etorphine alone.
Anion gap decreased, likely caused by the lactic acid-
osis. K increased between the samples in spite of an in-
crease in pH. As an increased pH will usually decrease
K, the increased K likely reflects that K has leaked out of
damaged cells, possibly muscular cells. The decrease in
Hb and Hct could be a result of sequestration of ery-
throcytes in the spleen or increased intravascular fluid
volume due to diffusion of interstitial fluid into the vas-
cular space. This usually happens during anaesthesia due
to vasodilatation and decreased blood pressure, which is
consistent with xylazine and acepromazine anesthesia in
some ruminants, however the etorphine usually causes
increased blood pressure.
Conclusions
Moose immobilized with etorphine-xylazine-acepromazine
exhibited mild to severe hypoxemia, mild to moderate
hypercapnia and moderate to marked acidemia.
Too far reaching comparative conclusions of this study
should be cautioned, as it is hard to do cross compari-
sons among populations as physiological responses to
anesthesia might vary in terms of body condition, age
distribution and time of the year. The mean induction
time for the 12 moose immobilized with one dart in our
study was over 2 minutes longer than the 4.4 ±2.6 min-
utes reported in etorphine-immobilized moose [20].
Physiological assessment of other immobilizing agents
for moose including thiafentanil and etorphine, for
anesthesia of moose and evaluation of oxygen supple-
mentation for correction of hypoxemia is warranted.
Abbreviations
AG: Anion gap; BE: Base excess; Cl: Chloride; HCO3: Bicarbonate;
PB: Barometric pressure; CO2: Carbon dioxide; FiO2: Fraction of inspired
oxygen (0.21); GPS: Global positioning systems; K: Potassium; Na: Sodium;
Evans et al. Acta Veterinaria Scandinavica 2012, 54:77 Page 5 of 7
http://www.actavetscand.com/content/54/1/77PaCO2: Partial pressure of arterial carbon dioxide; PAO2: Alveolar oxygen
tension; PaO2: Partial pressure of arterial oxygen; PH2O: Saturated vapor
pressure for water at 37°C (47 mmHg); RQ: Respiratory quotient;
SaO2%: Percent oxygen hemoglobin saturation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AE participated in study design, carried out the field sampling, data
collection and analysis and drafted the manuscript. ÅF participated in design
of the study, presentation of data and drafting the manuscript. AH
participated in study design and interpretation of results. GE participated in
design of the study, statistical analysis and coordinated field logistics. JMA
conceived of the study, participated in its design and coordination and
helped to draft the manuscript. All authors have critically revised the
manuscript and read and approved the final manuscript.
Acknowledgements
Eric Andersson and Åke Nordström from the Swedish University of
Agricultural Science performed the moose captures and facilitated the
logistics for this study. Tjarda Roberts at the Norwegian Polar institute
consulted on the statistical analysis. The Wildlife & Forestry program at the
Swedish University of Agricultural Science and the program ICEMOOSE of
the Swedish University of Agricultural Science, the Swedish Association of
Hunting and Wildlife Management, Sveaskog and the ICEHOTEL supported
this project. The iSTAT machine was provided by the Norwegian School of
Veterinary Science and stipend support for the first author was from the US-
Norway Fulbright Foundation, the American Scandinavian Foundation and
the Morris Animal Foundation.
Author details
1Department of Forestry and Wildlife Management, Hedmark University
College, Campus Evenstad, Koppang NO-2480, Norway.
2Section of Arctic
Veterinary Medicine, Norwegian School of Veterinary Science, Tromsø
NO-9292, Norway.
3Faculty of Veterinary Medicine and Animal Science,
Swedish University of Agricultural Sciences, Uppsala SE-750 07, Sweden.
4Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T2N
4N1, Canada.
5Department of Wildlife, Fish and Environmental Studies,
Swedish University of Agricultural Sciences, Umeå SE-901 83, Sweden.
6Department of Clinical Sciences, Norwegian School of Veterinary Science,
Oslo NO-0033, Norway.
Received: 16 June 2012 Accepted: 16 December 2012
Published: 31 December 2012
References
1. Arnemo JM, Kreeger TJ, Soveri T: Chemical immobilization of free-ranging
moose. Alces 2003, 39:243–253.
2. Kreeger TJ, Arnemo JM: Handbook of wildlife chemical immobilization 4th ed.
3rd edition. Wheatland, Wyoming: Terry J. Kreeger; 2012.
3. Kreeger T, Edwards W, Wald E, Becker S, Brimeyer D, Fralick G, Berger J:
Health assessment of Shiras moose immobilized with thiafentanil. Alces
2005, 41:121–128.
4. Arnemo JM, Ericsson G, Oen EO, Broman E, Heim M, Wallin K, Os O, Ball J:
Immobilization of free-ranging moose (Alces alces) with etorphine or
etorphine-acepromazine-xylazine in Scandinavia 1984–2003: A review of
2,754 captures. Proceedings AAZV, AAWV, WDA Joint Conference 2004,
2004:515–516.
5. Delvaux H, Courtois R, Breton L, Patenaude R: Relative efficiency of
succinylcholine, xylazine, and carfentanil/xylazine mixtures to immobilize
free-ranging moose. J Wildl Dis 1999, 35:38–48.
6. Seal US, Schmitt SM, Peterson RO: Carfentanil and xylazine for
immobilization of moose (Alces alces) on Isle Royale. J Wildl Dis 1985,
21:48–51.
7. Cattet M, Boulanger J, Stenhouse G, Powell RA, Reynolds-Hogland MJ: An
evaluation of long-term capture effects in ursids: Implications for wildlife
welfare and research. J Mammal 2008, 89:973–990.
8. Larsen DG, Gauthier DA: Effects of capturing pregnant moose and calves
on calf survivorship. J Wildl Manag 1989, 53:564–567.
9. Neumann W, Ericsson G, Dettki H, Arnemo J: Effect of immobilizations on
female moose (Alces alces) activity and space use. Can J Zool 2011,
89:1013–1018.
10. Gutierrez G: Hypoxia and hypoxemia. In Encyclopedia of respiratory
medicine. Edited by Geoffrey JL, Steven DS. Oxford: Academic; 2006:302–307.
11. Siesjö B: Acidosis and ischemic brain damage. Mol Chem Neuropathol
1988, 9:31–88.
12. Wang P, Ba ZF H, Chaudry I: Severe hypoxemia in the absence of blood
loss depresses hepatocellular function and up-regulates IL-6 and PGE2.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1997,
1361:42–48.
13. Dyson A, Stidwill R, Taylor V, Singer M: Tissue oxygen monitoring in
rodent models of shock. Am J Physiol Heart Circ Physiol 2007, 293:526–533.
14. Evans RG, Goddard D, Eppel GA, O’Connor PM: Factors that render the
kidney susceptible to tissue hypoxia in hypoxemia. Am J Physiol Regul
Integr Comp Physiol 2011, 300:R931–R940.
15. Braaksma MA, Dassel ACM, Aarnoudse JG: Renal responses to prolonged
(48 h) hypoxemia without acidemia in the late-gestation ovine fetus. Am
J Physiol Regul Integr Comp Physiol 1999, 277:R395–R402.
16. Rees S, Breen S, Loeliger M, McCrabb G, Harding R: Hypoxemia near mid-
gestation has long-term effects on fetal brain development.
J Neuropathol Exp Neurol 1999, 58:932–945.
17. Ericsson GWK: Senescence in a northern ungulate: Age and sex-specific
patterns of mortality in moose. Ecoscience 2001, 8:157–163.
18. Jalanka HH, Roeken BO: The use of medetomidine, medetomidine-
ketamine combinations, and atipamezole in nondomestic mammals: a
review. J Zoo Anim Med 1990, 21:259–282.
19. Schmidt-Nielsen K: Animal physiology: adaptation and environment.
Cambridge, England: Cambridge University Press; 1997.
20. Haga HA, Wenger S, Hvarnes S, Os O, Rolandsen CM, Solberg EJ: Plasma
lactate concentrations in free-ranging moose (Alces alces) immobilized
with etorphine. Vet Anaesth Analg 2009, 36:555–561.
21. Lynch GM, Hanson JA: Use of etorphine to immobilize moose. J Wildl
Manag 1981, 45:981–985.
22. Kreeger TJ: Xylazine-induced aspiration pneumonia in Shira’s moose.
Wildl Soc Bull 2000, 28:751–753.
23. Arnemo JM, Ahlqvist P, Andersen R, Berntsen F, Ericsson G, Odden J,
Brunberg S, Segerstrom P, Swenson JE: Risk of capture-related mortality in
large free-ranging mammals: experiences from Scandinavia. Wildl Biol
2006, 12:109–113.
24. Gustein HB, Akil H: Opioid analgesics. In Goodman & Gilman’s the
pharmacological basis of therapeutics. 11th edition. Edited by Brunton LL.
New York: McGraw/Hill; 2006:560–568.
25. Grimm KA, Lamont L: Clinical pharmacology. In Zoo animal and wildlife
immobilization and anesthesi. 1st edition. Edited by West G, Heard D,
Caulket N. Ames, Iowa, USA: Wiley-Blackwell; 2008:3–36.
26. Celly CS, Atwal OS, McDonell WN, Black WD: Histopathologic alterations
induced in the lungs of sheep by use of alpha(2)-adrenergic receptor
agonists. Am J Vet Res 1999, 60:154–161.
27. Caulkett NA, Cattet MR, Cantwell S, Cool N, Olsen W: Anesthesia of wood
bison with medetomidine-zolazepam/tiletamine and xylazine-
zolazepam/tiletamine combinations. Can Vet J 2000, 41:49–53.
28. Caulkett NA, Cribb PH, Haigh JC: Comparative cardiopulmonary effects of
carfentanil-xylazine and medetomidine-ketamine used for
Immobilization of mule deer and mule deer/white-tailed deer hybrids.
Can J Vet Res 2000, 64:64–68.
29. Read M, Caulkett NA, Symington A, Shury TK: Treatment of hypoxemia
during xylazine-tiletamine-zolazepam immobilization of wapiti. Can Vet J
2001, 42:861–864.
30. Storms TN, Schumacher J, Zagaya N, Osborn DA, Miller KV, Ramsay EC:
Determination and evaluation of an optimal dosage of carfentanil and
xylazine for the immobilization of white-tailed deer (Odocoileus
virginianus). J Wildl Dis 2005, 41:559–568.
31. Siegal-Willott J, Citino SB, Wade S, Elder L, Hayek LA, Lance WR:
Butorphanol, azaperone, and medetomidine anesthesia in free-ranging
white-tailed deer (Odocoileus virginianus) using radiotransmitter darts.
J Wildl Dis 2009, 45:468–480.
32. Paterson JM, Caulkett NA, Woodbury MR: Physiologic effects of nasal
oxygen or medical air administered prior to and during carfentanil-
xylazine anesthesia in North American elk (Cervus canadensis
manitobensis). J Zoo Wildl Med 2009, 40:39–50.
Evans et al. Acta Veterinaria Scandinavica 2012, 54:77 Page 6 of 7
http://www.actavetscand.com/content/54/1/7733. Read MR: A review of alpha-2 adrenoreceptor agonists and the
development of hypoxemia in domestic and wild ruminants. J Zoo Wildl
Med 2003, 34:134–138.
34. West JB: Respiratory Physiology. 8th edition. Hong Kong: Lipincott Williams &
Wilkins; 2008:186.
35. Johnson RA, Morais HA: Respiratory acid–base disorders. In Fluid, electrolyte
and acid–base disorders. Edited by DiBartola SP. St. Louis, Missouri: Elsevier
Inc; 2011:287–301.
36. Forster HV, Dempsey JA, Thomson J, Vidruk E, DoPico GA: Estimation of
arterial PO2, PCO2, pH, and lactate from arterialized venous blood. J Appl
Physiol 1972, 32:134–137.
doi:10.1186/1751-0147-54-77
Cite this article as: Evans et al.: Physiological evaluation of free-ranging
moose (Alces alces) immobilized with etorphine-xylazine-acepromazine
in Northern Sweden. Acta Veterinaria Scandinavica 2012 54:77.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Evans et al. Acta Veterinaria Scandinavica 2012, 54:77 Page 7 of 7
http://www.actavetscand.com/content/54/1/77